The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Caselli, E.
Right arrow Articles by Caputo, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caselli, E.
Right arrow Articles by Caputo, A.
The Journal of Immunology, 1999, 162: 5631-5638.
Copyright © 1999 by The American Association of Immunologists

DNA Immunization with HIV-1 tat Mutated in the trans Activation Domain Induces Humoral and Cellular Immune Responses Against Wild-Type Tat1

Elisabetta Caselli*, Monica Betti*, Maria Pia Grossi*, Pier Giorgio Balboni*, Cristina Rossi*, Chiara Boarini*, Aurelio Cafaro{dagger}, Giuseppe Barbanti-Brodano*, Barbara Ensoli{dagger} and Antonella Caputo2,*

* Department of Experimental and Diagnostic Medicine, Section of Microbiology, and Interdepartmental Center for Biotechnology, University of Ferrara, Ferrara, Italy; and {dagger} Laboratory of Virology, Istituto Superiore di Sanità, Rome, Italy

Intramuscular immunization of mice with plasmids encoding two transdominant negative mutants of the HIV-1 Tat protein (Tat22 and Tat22/37) elicited a humoral response to wild-type Tat that is comparable to that induced by inoculation of wild-type tat DNA or Tat protein. The percentage of the responders and the Ab titers continued to increase after three additional DNA boosts and pretreatment with bupivacaine at the site of inoculation, without a significant difference (p > 0.05) among the three groups of mice immunized with mutant and wild-type tat genes. By utilizing synthetic peptides representing the amino acid sequence of Tat, one major B cell epitope was defined within the cysteine-rich domain of Tat. Anti-Tat IgG Abs directed against this epitope were found in mice immunized with all tat DNA constructs, whereas different Tat epitopes were detected in mice immunized with the Tat protein. Similarly, IgG2a was the predominant isotype in DNA-immunized mice, with both mutants and wild-type tat genes, as compared with protein immunization, which induced mostly IgG1 and IgG3. Sera from most immunized mice neutralized the effect of extracellular Tat in activating HIV-1 replication. A cellular response was also elicited as indicated by the proliferation of splenocytes when stimulated with wild-type Tat. These results indicate that the wild-type Tat Ag is recognized by Abs and T cells induced by DNA immunization with mutated tat genes, suggesting the possible use of these Tat transdominant mutants, lacking viral trans activation activity and capable of blocking wild-type Tat activity, in the development of an anti-HIV-1 vaccine.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
E. Fanales-Belasio, S. Moretti, V. Fiorelli, A. Tripiciano, M. R. Pavone Cossut, A. Scoglio, B. Collacchi, F. Nappi, I. Macchia, S. Bellino, et al.
HIV-1 Tat Addresses Dendritic Cells to Induce a Predominant Th1-Type Adaptive Immune Response That Appears Prevalent in the Asymptomatic Stage of Infection
J. Immunol., March 1, 2009; 182(5): 2888 - 2897.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
L. Mascarell, C. Fayolle, C. Bauche, D. Ladant, and C. Leclerc
Induction of Neutralizing Antibodies and Th1-Polarized and CD4-Independent CD8+ T-Cell Responses following Delivery of Human Immunodeficiency Virus Type 1 Tat Protein by Recombinant Adenylate Cyclase of Bordetella pertussis
J. Virol., August 1, 2005; 79(15): 9872 - 9884.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
T. J. Ruckwardt, I. Tikhonov, S. Berg, G. S. Hatfield, A. Chandra, P. Chandra, B. Gilliam, R. R. Redfield, R. C. Gallo, and C. D. Pauza
Sequence Variation within the Dominant Amino Terminus Epitope Affects Antibody Binding and Neutralization of Human Immunodeficiency Virus Type 1 Tat Protein
J. Virol., December 1, 2004; 78(23): 13190 - 13196.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
L. Ramakrishna, K. K. Anand, K. M. Mohankumar, and U. Ranga
Codon Optimization of the Tat Antigen of Human Immunodeficiency Virus Type 1 Generates Strong Immune Responses in Mice following Genetic Immunization
J. Virol., September 1, 2004; 78(17): 9174 - 9189.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
E. Caselli, M. Boni, A. Bracci, A. Rotola, C. Cermelli, M. Castellazzi, D. Di Luca, and E. Cassai
Detection of Antibodies Directed against Human Herpesvirus 6 U94/REP in Sera of Patients Affected by Multiple Sclerosis
J. Clin. Microbiol., November 1, 2002; 40(11): 4131 - 4137.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Fanales-Belasio, S. Moretti, F. Nappi, G. Barillari, F. Micheletti, A. Cafaro, and B. Ensoli
Native HIV-1 Tat Protein Targets Monocyte-Derived Dendritic Cells and Enhances Their Maturation, Function, and Antigen-Specific T Cell Responses
J. Immunol., January 1, 2002; 168(1): 197 - 206.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S.-A. Chen, M.-H. T. F.-T. Wu, A. Hsiang, Y.-L. Chen, H.-Y. Lei, T.-S. Tzai, H. W. C. Leung, Y.-T. Jin, C.-L. Hsieh, L.-H. Hwang, et al.
Induction of Antitumor Immunity with Combination of HER2/neu DNA Vaccine and Interleukin 2 Gene-modified Tumor Vaccine
Clin. Cancer Res., November 1, 2000; 6(11): 4381 - 4388.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.